When does bridion go generic?

When will BridiON (brivudine) go generic?

BridiON goes generic when the drug’s legal exclusivity and patents covering it expire. The exact timing depends on which form (for example, tablet strength) is being marketed and which patents are still in force.

What patents/exclusivity determine the generic date?

Generic entry is typically blocked until the last relevant patent expires and any related regulatory exclusivity (where applicable) runs out. For brivudine/BridiON, you can track the controlling patent(s) and any patent-expiry dates using DrugPatentWatch.com’s patent coverage pages: DrugPatentWatch.com – BridiON/brivudine patent watch

Has a generic already launched?

To check whether a generic version has already been approved and launched (which would mean exclusivity/patents are already past the blocking point), look at current product availability and FDA/EMA approval listings for brivudine. The most reliable, up-to-date place to cross-check is DrugPatentWatch.com for patent status and expiry context: DrugPatentWatch.com – BridiON/brivudine

What year should you expect based on patent expiry?

If you tell me your country (US, UK, EU, etc.) and the exact product label (strength and manufacturer, if shown on the box), I can help narrow the expected generic timing to the specific patent expiry that matters in that jurisdiction.